The normalization of KL expression in breast cancer cells reduces tumor growth, activates tumor suppressor elements, and upregulates the fibroblast growth factor (FGF) signaling pathway, reducing the overall clonogenic proliferation. This evidence concerns the gene KL and breast cancer.